Trade Summary

5 days ago, Garland Jason K, serving as CFO at REPLIGEN CORP (RGEN), sold 530 shares at $150.00 per share, for a total transaction value of $79,500.00. Following this transaction, Garland Jason K now holds 18,829 shares of RGEN.

This sale represents a 2.74% decrease in Garland Jason K's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 16, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 17, 2026 at 4:40 PM ET, 1 day after the trade was made.

REPLIGEN CORP operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.